Your browser doesn't support javascript.
loading
Differentiation of malignant brain tumor types using intratumoral and peritumoral radiomic features.
Liu, Dongming; Chen, Jiu; Ge, Honglin; Hu, Xinhua; Yang, Kun; Liu, Yong; Hu, Guanjie; Luo, Bei; Yan, Zhen; Song, Kun; Xiao, Chaoyong; Zou, Yuanjie; Zhang, Wenbin; Liu, Hongyi.
Afiliação
  • Liu D; Department of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Chen J; Institute of Neuropsychiatry, The Affiliated Brain Hospital of Nanjing Medical University, Fourth Clinical College of Nanjing Medical University, Nanjing, China.
  • Ge H; Department of Neurosurgery, Institute of Brain Sciences, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Hu X; Department of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Yang K; Department of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Liu Y; Department of Neurosurgery, Institute of Brain Sciences, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Hu G; Department of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Luo B; Department of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Yan Z; Department of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Song K; Department of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Xiao C; Department of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Zou Y; Department of Pathology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Zhang W; Department of Radiology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Liu H; Department of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
Front Oncol ; 12: 848846, 2022.
Article em En | MEDLINE | ID: mdl-35965511

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China